Regeneron beats second-quarter results estimates on Dupixent sales boost
Investors have set a high bar for Regeneron and French partner Sanofi's (SASY.PA), opens new tab Dupixent, one of the U.S. drugmaker's growth drivers, especially after it received approval to treat a common lung condition called chronic obstructive pulmonary disease last year.
Sales of the anti-inflammatory drug rose 22% to $4.34 billion, compared with an estimate of $4.14 billion.
The Tarrytown, New York-based company is also banking its cancer treatment, Libtayo, to drive future growth at a time when its blockbuster eye disease drug Eylea has been grappling with stiff competition from cheaper versions and rival drugs such as Roche's (ROG.S), opens new tab Vabysmo.
U.S. sales of Eylea, jointly developed with Bayer AG (BAYGn.DE), opens new tab, fell 25% to $1.15 billion, including $393 million from the higher, 8-milligram dose version of the drug. Analysts were expecting $2.17 billion in total Eylea sales.
Roche reported Vabysmo sales of 2.07 billion Swiss francs ($2.54 billion) last week, slightly below analyst expectations.
On an adjusted basis, Regeneron earned a quarterly profit of $12.89 per share, compared with analysts' average expectation of $8.44 per share, according to data compiled by LSEG.
The company's total revenue for the quarter was $3.68 billion, above an expectation of $3.28 billion.
Skin cancer drug Libtayo brought in sales of $377 million, versus analysts' average estimate of $338.75 million.
Separately, Regeneron is among 17 drugmakers that have received a letter from the U.S. President Donald Trump asking them to slash U.S. prescription drug prices to match overseas rates.
($1 = 0.8161 Swiss francs)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
24 minutes ago
- Reuters
Oil steadies on potential Trump-Putin meeting in coming days
LONDON, Aug 7 (Reuters) - Oil prices steadied on Thursday, paring early gains after the Kremlin announced that Russian President Vladimir Putin will meet U.S. President Donald Trump in the coming days, raising expectations for a diplomatic end to the war in Ukraine. Brent crude futures were up 21 cents, or 0.3%, at $67.1 a barrel by 0902 GMT while U.S. West Texas Intermediate crude gained 20 cents, or 0.3%, to $64.55. Both benchmarks slid about 1% on Wednesday, touching their lowest in eight weeks, after comments from Trump on progress in talks with Moscow. Kremlin aide Yuri Ushakov said on Thursday that Trump and Putin will meet in the coming days in what would be the first summit between leaders of the two countries since 2021. A White House official had previously said that Trump could meet Putin as soon as next week, though the U.S. continued preparations to impose secondary sanctions, potentially including China, to pressure Moscow to end the war in Ukraine. Oil is modestly up, benefiting from a crude draw in the U.S., higher Saudi prices for Asia and solid Chinese crude imports in July, said UBS analyst Giovanni Staunovo, adding that gains were curbed by news of the potential Trump-Putin meeting next week. Russia is the world's second-biggest producer of oil behind the United States. The Energy Information Administration said on Wednesday that U.S. crude oil stockpiles fell by 3 million barrels to 423.7 million barrels in the week ended August 1, exceeding an expected decline of 591,000 barrels in a Reuters poll of analysts. In China, crude oil imports in July dipped 5.4% from June but were still up 11.5% year on year, with analysts expecting refining activity to remain firm in the near term. Saudi Arabia, the world's biggest oil exporter, on Wednesday raised its September crude oil prices for Asian buyers, the second monthly rise in a row, on tight supply and robust demand. Global macroeconomic uncertainty capped price gains, however, after the U.S. ordered a fresh set of tariffs on Indian goods. Trump imposed an additional 25% tariff on Indian goods on Wednesday, citing the country's continued imports of Russian oil. The new import tax will take effect on August 28. Trump also said he could announce further tariffs on China.
Reuters
24 minutes ago
- Reuters
European shares tick higher with earnings, tariffs in focus
Aug 7 (Reuters) - European shares ticked higher on Thursday, as investors weighed mixed earnings reports and the impact from higher U.S. tariffs on a dozen of its trading partners that are expected to weigh on global growth and rekindle inflation. The pan-European STOXX 600 index (.STOXX), opens new tab rose 0.6%, as of 0855 GMT, with most major regional bourses trading higher. Britain's blue-chip FTSE 100 (.FTSE), opens new tab, however, dipped 0.3% ahead of a Bank of England meeting where policymakers are widely expected to cut interest rates. U.S. President Donald Trump's higher tariffs kicked in on Thursday, including a 39% rate on Switzerland. Swiss President Karin Keller-Sutter left Washington on Wednesday after failing to meet with Trump or any top trade officials, a source told Reuters. Trump also said the United States will impose a tariff of about 100% on imports of semiconductors but offered up a big exemption - it will not apply to companies that are manufacturing in the U.S. or have committed to do so. European tech stocks (.SX8P), opens new tab, particularly those of chipmakers, climbed on relief that there will be no charge on companies such as Apple that has committed to build in the United States. European chipmakers BE Semiconductor ( opens new tab, ASML Holding ( opens new tab and SAP ( opens new tab were all up over 2%. Broad hopes that tech companies will be spared from Trump's big tariffs helped offset weak economic data and some earnings disappointments. German industrial output fell in June to its lowest level since the pandemic, with exports rising more than expected amid weak foreign demand and increased competition from China. In earnings, Rheinmetall ( opens new tab was among top laggards on the index, falling 5.2%, after the German defence company missed second-quarter sales expectations partially due to a delay in German defence contracts being awarded. On the flip side, Maersk ( opens new tab rose 2.5% after the shipping group raised its full-year profit outlook on global demand for ocean container freight. "I think it's safe to say the impact on profits in this quarter has been negative but not as bad as expected," said Daniel Morris, chief market strategist at BNP Paribas Asset Management. "One of the reasons is you'd already priced in that impact on profits and it's turned out to be a little bit better than you thought." Of the 198 companies in the STOXX 600 that reported earnings through Tuesday, 53% exceeded analysts' estimates, as per data compiled by LSEG. In a typical quarter, 54% beat forecasts. Telecommunication stocks (.SXKP), opens new tab were under pressure after Freenet AG ( opens new tab and DT Telekom ( opens new tab fell 5.3% and 3.6%, respectively, after their quarterly results. Austria's Raiffeisen Bank International ( opens new tab jumped to the top of STOXX 600, adding 10.3% after a Russian court lifted a temporary freeze of the bank's Russian unit shares. InterContinental Hotels Group (IHG.L), opens new tab rose 6% after posting a strong half-year revenue and maintaining full-year targets. Merck KGaA ( opens new tab fell 1.4% after the German drugmaker narrowed its guidance range for organic sales and posting a lower second-quarter adjusted EBITDA due to a weaker dollar.
Reuters
24 minutes ago
- Reuters
US eyes 7% more nuclear power through restarts, upgrades
August 7 - As soaring AI use hikes demand for new power capacity, U.S. utilities are restarting mothballed nuclear plants as well as 'uprating' the capacity and extending the licences of operational reactors. A number of Big Tech companies are seeking nuclear power to provide dispatchable low carbon energy and in May President Trump rolled out several policies to increase existing nuclear capacity alongside measures to accelerate the deployment of small modular reactors (SMRs) and larger conventional reactors. Trump wants the U.S. to increase the capacity of existing reactors by 5 GW by 2030. Holtec International and Constellation are restarting two nuclear facilities with a combined nameplate capacity of 1.6 GW. NextEra Energy spoke with regional grid operators and filed notice with federal regulators to potentially restart the 600 MW Duane Arnold nuclear plant in Iowa, NextEra Energy CEO John Ketchum told Reuters in January. Restarts and upgrades could increase the country's nuclear net generation capacity by around 7% from 97 GW today, if Trump's targets are met. MAP: US nuclear power plants in operation Restarting a mothballed nuclear facility offers a faster timeline and lower upfront costs than building a new one from scratch but is still an arduous process that requires several years for planning, licensing, inspections, equipment purchases, refurbishment, workforce training and fuel management actions. Holtec is on track to restart the 800 MW Palisades nuclear plant in Michigan this year following its announcement of the project in the summer of 2022. On July 24, the Nuclear Regulatory Commission (NRC) moved Palisades from "decommissioning" to 'operating' status, ahead of schedule. Faster regulatory approval and long-term power purchase agreements (PPAs) with offtakers are important for raising funds from investors such as venture capital and private equity groups, Patrick O'Brien, Director, Government Affairs and Communications at Holtec International, told Reuters Events. Faster approvals lead to shorter project durations and lower costs and in May Trump ordered the NRC to accelerate its licensing processes. The presidential orders have led to 'improved timelines' in Holtec's dealings with the regulator, O'Brien said. Join 3,000+ senior decision-makers across energy and finance at Reuters Events Energy LIVE 2025. The process of switching the Palisades license from "decommissioning" to 'operating' was especially cumbersome for the NRC because it was a first-of-a-kind process, said Katy Huff, Associate Professor and Director, Advanced Reactor Fuel Cycles Laboratory at the University of Illinois at Urbana-Champaign. 'I expect the reviews of [Constellation's] Crane Clean Energy Center and [NextEra's] Duane Arnold plant will go more quickly,' she said. Crucial steps Holtec's signing of a long-term PPA in 2023 with Wolverine Power Cooperative in Michigan was 'the key piece' that allowed the company to move forward with the reopening of Palisades, O'Brien said. Long-term certainty helps 'put shovels in the ground and get some of these projects done,' he said. As AI demand soars, power-hungry tech groups are keen to sign long-term deals and can be willing to pay a premium for clean power, O'Brien noted. CHART: Forecast US data center electricity demand Constellation Energy is investing $1.6 billion to reopen the 837 MW Three Mile Island Unit 1 in Pennsylvania in 2027, now called the Crane Clean Energy Center, on the back of a 20-year PPA to supply clean power to Microsoft data centers. The plant could restart as early as 2027, a year ahead of schedule, following 'the approval of an early interconnection request by grid operator PJM and significant progress made on hiring, reactor operator training and major equipment purchases,' Constellation said in June. Re-staffing shuttered nuclear facilities is a 'key challenge' in the restarting process, Huff said. 'Bringing these nuclear plants back online will require a talented pool of technicians and trades workers, such as welders and electricians certified in nuclear-specific codes and standards," she told Reuters Events. "Recruiting and training staff to refurbish and run these plants may require significant effort.' Palisades had around 200 workers while it was inactive and by July Holtec was close to reaching a fully-staffed level of around 600 people. Re-staffing takes time because extensive training is necessary to 'build a culture of safety' among nuclear workers, O'Brien said. Securing community support is also essential but less challenging than in the past, O'Brien said, pointing to a June 2025 poll by the non-partisan Pew Research group that showed that about six-in-ten (59%) Americans now back new nuclear power capacity to generate electricity. Limited number While growing demand has improved the business case for restarts, most reactors that have entered the decommissioning process will not be suitable, Huff said. 'Only reactors which have been shut down recently and retain infrastructure that is largely intact stand a realistic chance of restart," Huff said. "Reactors further along in decommissioning face more substantial hurdles, primarily due to the economic requirements of refurbishment." Download our exclusive report: US Energy Strategies Under Trump 2.0 Meanwhile, Trump's goal of adding 5 GW of nuclear capacity through plant uprates by 2030 is "ambitious but possible," Huff said. The NRC approved 6 GW of uprates over the past 20 years and is currently expecting applications for a further 2 GW, she said. Constellation is 'working to secure customer commitments' to increase the capacity of its 2.3 GW Limerick Clean Energy Center in Pennsylvania by 340 MW, the company said on July 15. Duke Energy is seeking to add 300 MW of capacity in the Carolinas through power uprate projects at Catawba Nuclear Station, McGuire Nuclear Station and Brunswick Nuclear Plant, as well as a 45 MW uprate project at Oconee Nuclear Station that was finalized in 2024. 'To help meet growth needs in the Carolinas by the early 2030s, we'll have added the equivalent of a new small modular reactor by increasing the output of our existing nuclear fleet,' Steven Capps, senior vice president New Nuclear Generation and Operations Support at Duke Energy, told Reuters Events. For exclusive insights on the energy transition, sign up to our newsletter. Utilities are increasingly eager to extend the licences of existing reactors. Some 24 of the 94 operational U.S. nuclear reactors have licenses that are set to expire prior to 2035, the DOE said in 2023. Duke Energy aims to extend the operating licenses of 11 reactors it has at its six nuclear facilities – three in North Carolina and another three in South Carolina. Constellation is pursuing license renewals across its fleet of 21 nuclear reactors, including a 20-year extension for the 1.1 GW Clinton nuclear facility in Illinois, which is currently being reviewed by the NRC. Constellation's deal with Meta in June includes a 20-year PPA to provide clean power from the Clinton facility. Constellation's CEO Joe Dominguez said the partnership shows 'the relicensing and expansion of existing plants is just as impactful as finding new sources of energy.'
